Clinical Trial Update: A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes ABX-001, an experimental immunotherapy, given alone and in combination with pembrolizumab for advanced solid tumors. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ABX-001
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Abalos Therapeutics GmbH | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING